Literature DB >> 24998253

The use of fluorescent target arrays for assessment of T cell responses in vivo.

Benjamin J C Quah1, Danushka K Wijesundara2, Charani Ranasinghe2, Christopher R Parish2.   

Abstract

The ability to monitor T cell responses in vivo is important for the development of our understanding of the immune response and the design of immunotherapies. Here we describe the use of fluorescent target array (FTA) technology, which utilizes vital dyes such as carboxyfluorescein succinimidyl ester (CFSE), violet laser excitable dyes (CellTrace Violet: CTV) and red laser excitable dyes (Cell Proliferation Dye eFluor 670: CPD) to combinatorially label mouse lymphocytes into > 250 discernable fluorescent cell clusters. Cell clusters within these FTAs can be pulsed with major histocompatibility (MHC) class-I and MHC class-II binding peptides and thereby act as target cells for CD8(+) and CD4(+) T cells, respectively. These FTA cells remain viable and fully functional, and can therefore be administered into mice to allow assessment of CD8(+) T cell-mediated killing of FTA target cells and CD4(+) T cell-meditated help of FTA B cell target cells in real time in vivo by flow cytometry. Since > 250 target cells can be assessed at once, the technique allows the monitoring of T cell responses against several antigen epitopes at several concentrations and in multiple replicates. As such, the technique can measure T cell responses at both a quantitative (e.g. the cumulative magnitude of the response) and a qualitative (e.g. functional avidity and epitope-cross reactivity of the response) level. Herein, we describe how these FTAs are constructed and give an example of how they can be applied to assess T cell responses induced by a recombinant pox virus vaccine.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24998253      PMCID: PMC4195613          DOI: 10.3791/51627

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  22 in total

1.  New and improved methods for measuring lymphocyte proliferation in vitro and in vivo using CFSE-like fluorescent dyes.

Authors:  Benjamin J C Quah; Christopher R Parish
Journal:  J Immunol Methods       Date:  2012-02-21       Impact factor: 2.303

2.  Fluorescent target array killing assay: a multiplex cytotoxic T-cell assay to measure detailed T-cell antigen specificity and avidity in vivo.

Authors:  Benjamin J C Quah; Danushka K Wijesundara; Charani Ranasinghe; Christopher R Parish
Journal:  Cytometry A       Date:  2012-06-27       Impact factor: 4.355

3.  Multiplexed labeling of viable cells for high-throughput analysis of glycine receptor function using flow cytometry.

Authors:  Daniel F Gilbert; John C Wilson; Virginia Nink; Joseph W Lynch; Geoffrey W Osborne
Journal:  Cytometry A       Date:  2009-05       Impact factor: 4.355

4.  ELISPOT assay to detect cytokine-secreting murine and human cells.

Authors:  Dennis Klinman
Journal:  Curr Protoc Immunol       Date:  2008-11

5.  Detection of intracellular cytokines by flow cytometry.

Authors:  Barbara Foster; Calman Prussin; Fei Liu; Jason K Whitmire; J Lindsay Whitton
Journal:  Curr Protoc Immunol       Date:  2007-08

6.  A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells.

Authors:  C C Czerkinsky; L A Nilsson; H Nygren; O Ouchterlony; A Tarkowski
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

7.  Caveats in the design of MHC class I tetramer/antigen-specific T lymphocytes dissociation assays.

Authors:  Xiaochi L Wang; John D Altman
Journal:  J Immunol Methods       Date:  2003-09       Impact factor: 2.303

8.  The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.

Authors:  Ian F Hermans; Jonathan D Silk; Jianping Yang; Michael J Palmowski; Uzi Gileadi; Corinna McCarthy; Mariolina Salio; Franca Ronchese; Vincenzo Cerundolo
Journal:  J Immunol Methods       Date:  2004-02-01       Impact factor: 2.303

Review 9.  Mechanisms behind functional avidity maturation in T cells.

Authors:  Marina Rode von Essen; Martin Kongsbak; Carsten Geisler
Journal:  Clin Dev Immunol       Date:  2012-04-26

10.  T cell affinity maturation by selective expansion during infection.

Authors:  D H Busch; E G Pamer
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

View more
  6 in total

1.  Whole-animal imaging and flow cytometric techniques for analysis of antigen-specific CD8+ T cell responses after nanoparticle vaccination.

Authors:  Lukasz J Ochyl; James J Moon
Journal:  J Vis Exp       Date:  2015-04-29       Impact factor: 1.355

2.  Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity.

Authors:  Jordi Ochando; Patricia Conde
Journal:  J Vis Exp       Date:  2017-06-07       Impact factor: 1.355

3.  An In Vivo Mouse Model to Measure Naïve CD4 T Cell Activation, Proliferation and Th1 Differentiation Induced by Bone Marrow-derived Dendritic Cells.

Authors:  Raquel Toribio-Fernandez; Virginia Zorita; Beatriz Herrero-Fernandez; Jose M Gonzalez-Granado
Journal:  J Vis Exp       Date:  2018-08-22       Impact factor: 1.355

4.  In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model.

Authors:  Cara L Haymaker; Yared Hailemichael; Yi Yang; Roza Nurieva
Journal:  J Vis Exp       Date:  2017-11-28       Impact factor: 1.355

5.  Acute T-Cell-Driven Inflammation Requires the Endoglycosidase Heparanase-1 from Multiple Cell Types.

Authors:  Zuopeng Wu; Rebecca A Sweet; Gerard F Hoyne; Charmaine J Simeonovic; Christopher R Parish
Journal:  Int J Mol Sci       Date:  2022-04-21       Impact factor: 6.208

6.  A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice.

Authors:  Khamis Tomusange; Danushka Wijesundara; Jason Gummow; Tamsin Garrod; Yanrui Li; Lachlan Gray; Melissa Churchill; Branka Grubor-Bauk; Eric J Gowans
Journal:  Sci Rep       Date:  2016-06-30       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.